Roivant Sciences (ROIV) Operating Income (2020 - 2025)
Historic Operating Income for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to -$339.2 million.
- Roivant Sciences' Operating Income fell 2360.66% to -$339.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.2 billion, marking a year-over-year decrease of 12732.26%. This contributed to the annual value of -$1.0 billion for FY2025, which is 12231.01% down from last year.
- As of Q4 2025, Roivant Sciences' Operating Income stood at -$339.2 million, which was down 2360.66% from -$306.2 million recorded in Q3 2025.
- Roivant Sciences' Operating Income's 5-year high stood at $5.1 billion during Q4 2023, with a 5-year trough of -$684.4 million in Q3 2021.
- In the last 5 years, Roivant Sciences' Operating Income had a median value of -$280.8 million in 2022 and averaged $64.2 million.
- As far as peak fluctuations go, Roivant Sciences' Operating Income plummeted by 33722.03% in 2021, and later skyrocketed by 145619.33% in 2023.
- Over the past 5 years, Roivant Sciences' Operating Income (Quarter) stood at -$246.0 million in 2021, then plummeted by 53.68% to -$378.1 million in 2022, then soared by 1456.19% to $5.1 billion in 2023, then crashed by 105.35% to -$274.4 million in 2024, then fell by 23.61% to -$339.2 million in 2025.
- Its Operating Income was -$339.2 million in Q4 2025, compared to -$306.2 million in Q3 2025 and -$284.9 million in Q2 2025.